CNS Pharma's Lead Drug Candidate Crosses The Blood Brain Barrier - What Does That Mean? Watch the full show here!

Watch the full show here!

John Climaco, Chairman & CEO of CNS Pharmaceuticals CNSP presented at Benzinga’s webinar: Pharma Companies Vs. A Tough Macro Backdrop.

The event brought together leaders from the pharmaceutical and biotech industries to discuss the prevailing economic headwinds and how to find success in such an environment. 

Mr. Climaco shared his valuable insights as well as exciting news from CNS Pharma, which develops innovative drugs that are capable of crossing the blood brain barrier in order to treat aggressive brain cancers.

Watch his presentation here:

Want to get involved in one of our events? Learn more here.

Featured photo by Milad Fakurian on Unsplash

This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.